Rituximab in the treatment of acquired factor VIII inhibitors.
Onitilo
Adedayo A
AA
Department of Hematology/Oncology, Marshfield Clinic-Weston Center, 3501 Cranberry Boulevard, Weston, WI 54476, USA. onitilo.adedayo@marshfieldclinic.org
Skorupa
Amy
A
Lal
Asheesh
A
Ronish
Elizabeth
E
Mercier
Richard J
RJ
Islam
Rezwan
R
Lazarchick
John
J
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000917:Antibody Formation; D001323:Autoantibodies / Q000097:blood*; D005169:Factor VIII / Q000276:immunology*; D005260:Female; D006467:Hemophilia A / Q000188:drug therapy* / Q000209:etiology; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D013927:Thrombosis / Q000209:etiology
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D007166:Immunosuppressive Agents; D000069283:Rituximab; D005169:Factor VIII